The analysis discusses Teva Pharmaceutical Industries, noting several negative signals but upgrading the analysis conclusion from a sell to a hold candidate. It identifies resistance at $19.68 and support at $16.83. The stock exhibits medium daily movements, indicating medium risk. A sell signal from a pivot top was found 12 days prior. Analyst ratings indicate a sell. The P/E ratio is -138.64. A suggested stop-loss is set at $17.91. Recent insider trading shows more sales than buys. Upward corrections may face resistance at $19.18 and $19.41. A breakout above these levels may issue buy signals, while a sell signal occurred from a pivot top on October 8, 2025. The trend suggests a potential change of 22.99% over the next 3 months with a possible return ranging from 22.99% to 35.93%. A 12-month analysis projects a change of -0.0951%, with performance fluctuating between -32.47% and 19.95%.